Metabolomics and machine learning approaches for diagnostic and prognostic biomarkers screening in sepsis.

Background: Sepsis is a life-threatening disease with a poor prognosis, and metabolic disorders play a crucial role in its development. This study aims to identify key metabolites that may be associated with the accurate diagnosis and prognosis of sepsis. Methods: Septic patients and healthy individ...

Descripción completa

Detalles Bibliográficos
Publicado en:BMC Anesthesiology Vol. 23; no. 1; pp. 1 - 14
Autores principales: She, Han, Du, Yuanlin, Du, Yunxia, Tan, Lei, Yang, Shunxin, Luo, Xi, Li, Qinghui, Xiang, Xinming, Lu, Haibin, Hu, Yi, Liu, Liangming, Li, Tao
Formato: pictorial research tables/charts Journal Article
Publicado: BioMed Central 11/9/2023
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=173514898&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 173514898
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        14712253
        1CH3
      jtl: BMC Anesthesiology
      issn: 14712253
      maglogo: N
    pubinfo:
      dt: 11/9/2023
      vid: 23
      iid: 1
      pid: 24147
      pub: BioMed Central
    artinfo:
      ui:
        173514898
        173514898
        173514898
        10.1186/s12871-023-02317-4
        173514898
      ppf: 1
      ppct: 13
      formats:
      tig:
        atl: Metabolomics and machine learning approaches for diagnostic and prognostic biomarkers screening in sepsis.
      aug:
        au:
          She, Han
          Du, Yuanlin
          Du, Yunxia
          Tan, Lei
          Yang, Shunxin
          Luo, Xi
          Li, Qinghui
          Xiang, Xinming
          Lu, Haibin
          Hu, Yi
          Liu, Liangming
          Li, Tao
        affil: Department of Anesthesiology, Daping Hospital, Army Medical University, 400042, Chongqing, China
      sug:
        subj:
          Sepsis Diagnosis
          Sepsis Prognosis
          Metabolites
          Machine Learning
          Biological Markers
          Health Screening
          Animal Studies
          Rats
          Models, Biological
          Mass Spectrometry
          Chromatography, High Pressure Liquid
          Cox Proportional Hazards Model
          Descriptive Statistics
          Comparative Studies
          Amino Acids Metabolism
          Phenylalanine Metabolism
          Tyrosine Metabolism
          Glycine Metabolism
          Serine Metabolism
          Threonine Metabolism
          Arginine Metabolism
          Proline Metabolism
          Algorithms
          Random Forest
          Sensitivity and Specificity
          Funding Source
      ab: Background: Sepsis is a life-threatening disease with a poor prognosis, and metabolic disorders play a crucial role in its development. This study aims to identify key metabolites that may be associated with the accurate diagnosis and prognosis of sepsis. Methods: Septic patients and healthy individuals were enrolled to investigate metabolic changes using non-targeted liquid chromatography-high-resolution mass spectrometry metabolomics. Machine learning algorithms were subsequently employed to identify key differentially expressed metabolites (DEMs). Prognostic-related DEMs were then identified using univariate and multivariate Cox regression analyses. The septic rat model was established to verify the effect of phenylalanine metabolism-related gene MAOA on survival and mean arterial pressure after sepsis. Results: A total of 532 DEMs were identified between healthy control and septic patients using metabolomics. The main pathways affected by these DEMs were amino acid biosynthesis, phenylalanine metabolism, tyrosine metabolism, glycine, serine and threonine metabolism, and arginine and proline metabolism. To identify sepsis diagnosis-related biomarkers, support vector machine (SVM) and random forest (RF) algorithms were employed, leading to the identification of four biomarkers. Additionally, analysis of transcriptome data from sepsis patients in the GEO database revealed a significant up-regulation of the phenylalanine metabolism-related gene MAOA in sepsis. Further investigation showed that inhibition of MAOA using the inhibitor RS-8359 reduced phenylalanine levels and improved mean arterial pressure and survival rate in septic rats. Finally, using univariate and multivariate cox regression analysis, six DEMs were identified as prognostic markers for sepsis. Conclusions: This study employed metabolomics and machine learning algorithms to identify differential metabolites that are associated with the diagnosis and prognosis of sepsis patients. Unraveling the relationship between metabolic characteristics and sepsis provides new insights into the underlying biological mechanisms, which could potentially assist in the diagnosis and treatment of sepsis. Trial registration: This human study was approved by the Ethics Committee of the Research Institute of Surgery (2021–179) and was registered by the Chinese Clinical Trial Registry (Date: 09/12/2021, ChiCTR2200055772).
      pubtype: Academic Journal
      doctype:
        pictorial
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N